Menlo Therapeutics, Inc. reported raising $50.5 Million in an initial SEC Form D filing, from an offering of $50.5 Million
PUBLIC · YARWJul 28, 2017
Amount Raised
$50.5 Million
$50.5 Million sold, per SEC Form D (first sale Jul 28, 2017)
Round Type
Venture
New HavenBiotechnologyHealthcareHealth CareTherapeuticsWho to call at Yarrow Bioscience, and when
A new round usually means Yarrow Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Yarrow Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Yarrow Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Yarrow Bioscience. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Yarrow Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
1 contact
Yarrow Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.